Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy
Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patie...
Saved in:
Published in | International journal of retina and vitreous Vol. 4; no. 1; pp. 41 - 5 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
02.11.2018
BMC |
Subjects | |
Online Access | Get full text |
ISSN | 2056-9920 2056-9920 |
DOI | 10.1186/s40942-018-0144-9 |
Cover
Abstract | Background
To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR).
Methods
Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed.
Results
Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption.
Conclusion
Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR. |
---|---|
AbstractList | Background
To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR).
Methods
Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed.
Results
Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption.
Conclusion
Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR. Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Results Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Conclusion Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR. To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902-0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936-0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR. Abstract Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR). Methods Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed. Results Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902–0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936–0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption. Conclusion Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR. To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR).BACKGROUNDTo evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical coherence tomography (SD-OCT) in patients of diabetic retinopathy (DR).Cross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed.METHODSCross sectional study including consecutive patients of type 2 diabetes mellitus [without DR (No DR, n = 97); non-proliferative DR (NPDR, n = 91); proliferative DR (PDR, n = 83)] and healthy controls (n = 82) was undertaken. CST and CAT values were measured using SD-OCT. Data was analyzed using Chi square test, ANOVA and multivariate analysis. Discriminant values of CST and CAT for EZ disruption were evaluated using receiver operator characteristic curve. Area under curve (AUC) was computed.Mean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902-0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936-0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption.RESULTSMean CAT and CST values in the study subjects showed an incremental trend. Multivariate ordinal logistic regression analysis showed increase in CST (OR = 1.022, p < 0.001) and CAT (OR = 1.029, p < 0.001) as significant independent predictors of EZ disruption. Area under curve showed excellent predictive results of CST (AUC = 0. 943 ± 0.021, 95% CI, 0.902-0.984, p < 0.05) and CAT (AUC = 0.959 ± 0.012, 95% CI 0.936-0.982, p < 0.05), as bioimaging biomarkers, for EZ disruption.Increase in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR.CONCLUSIONIncrease in CST and CAT is associated with increased odds of EZ disruption and these macular parameters serve as bioimaging biomarkers for EZ disruption in DR. |
ArticleNumber | 41 |
Author | Ahuja, Sukriti Meyer, Carsten H. Akduman, Levent Gilhotra, Jagjit S. Saxena, Sandeep |
Author_xml | – sequence: 1 givenname: Sukriti surname: Ahuja fullname: Ahuja, Sukriti organization: Department of Ophthalmology, King George’s Medical University – sequence: 2 givenname: Sandeep surname: Saxena fullname: Saxena, Sandeep email: sandeepsaxena2020@yahoo.com organization: Department of Ophthalmology, King George’s Medical University – sequence: 3 givenname: Carsten H. surname: Meyer fullname: Meyer, Carsten H. organization: Department of Ophthalmology, Pallas Klinik – sequence: 4 givenname: Jagjit S. surname: Gilhotra fullname: Gilhotra, Jagjit S. organization: Department of Ophthalmology, University of Adelaide – sequence: 5 givenname: Levent surname: Akduman fullname: Akduman, Levent organization: Department of Ophthalmology, Saint Louis University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30410791$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1v1DAQjVARLaU_gAuyxIVLwOPEcXxBQhUflSpxgbPlOOOst1l7sZNK7ZkfjkNa2FaCg-3x-L3np5l5Xhz54LEoXgJ9C9A271JNZc1KCm1edV3KJ8UJo7wppWT06CA-Ls5S2lJKoeEATf2sOK5oDVRIOCl-nqOfoh5JmjvrcOzJtHHmymNKRPuemLlDoq8x6gEPnxLpXHA7PTg_LOFOxyuMidgQCY6j26fgenKbLZPepTjvJxc8cT7fdIeTMyTm3Ye9njY3L4qnVo8Jz-7O0-L7p4_fzr-Ul18_X5x_uCwNh1aWIFuUreBoW90AQ8E15bbXXFgDUtcWTVUZaSsqBOUdAtOyQxRWVAIyrTotLlbdPuit2sfsP96ooJ36nQhxUDpmbyMqBtzqjoGoUNfUNLrBntJetKKxLOez1vtVaz93O-zNWsYHog9fvNuoIVyrhkENnGeBN3cCMfyYMU1q55LJtdMew5yyg4oxDpIvf71-BN2GOfpcqgXFoWaCLqhXh47-WLlvdgaIFWBiSCmiVcZNemlMNuhGBVQtk6XWyVJ5stQyWUpmJjxi3ov_j8NWTspYP2D8a_rfpF9YBOI2 |
CitedBy_id | crossref_primary_10_1016_j_jcjo_2024_12_006 crossref_primary_10_1007_s12020_019_02093_7 crossref_primary_10_1007_s00417_020_05039_2 crossref_primary_10_1080_08164622_2021_1896333 crossref_primary_10_1097_IAE_0000000000003473 crossref_primary_10_1007_s10792_021_01941_8 crossref_primary_10_1080_16089677_2021_1903170 crossref_primary_10_1038_s41433_024_03172_4 crossref_primary_10_1038_s41598_024_82007_4 |
Cites_doi | 10.1371/journal.pone.0081600 10.1186/2045-3701-4-27 10.1016/S0161-6420(13)38012-9 10.1016/j.survophthal.2008.10.001 10.1016/S0140-6736(09)62124-3 10.4103/0974-7788.59946 10.1016/j.jdiacomp.2016.01.010 10.1111/ceo.12506 10.1016/j.oret.2017.02.002 10.1186/s40662-015-0026-2 10.1016/j.ophtha.2006.10.055 10.1167/iovs.08-2970 10.1167/iovs.10-6518 10.2337/dc14-S081 10.1016/j.exer.2013.07.018 10.1016/j.jdiacomp.2015.12.009 10.1038/srep39161 10.1016/j.ajo.2009.08.037 10.2337/db07-0982 10.1186/s40942-016-0033-z |
ContentType | Journal Article |
Copyright | The Author(s) 2018 Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2018 – notice: Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s40942-018-0144-9 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection (Proquest) ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: 7X7 name: Proquest Health and Medical Complete url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2056-9920 |
EndPage | 5 |
ExternalDocumentID | oai_doaj_org_article_215fab2173ea40c6a6ed00d7876f2b21 PMC6214155 30410791 10_1186_s40942_018_0144_9 |
Genre | Journal Article |
GroupedDBID | 0R~ 53G 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML ABUWG ACGFS ADBBV ADRAZ ADUKV AFKRA AFPKN AHBYD AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS ASPBG BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EJD FYUFA GROUPED_DOAJ H13 HMCUK HYE IAO IEA IHR IHW ITC KQ8 M48 M~E OK1 PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ ROL RPM RSV SOJ UKHRP AAYXX CITATION 3V. ACRMQ ADINQ AHSBF C24 EMOBN NPM 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c5189-198e9875ef8a612e75a05fda57fc19a4fec33c9f307705be12a9bee7f737175e3 |
IEDL.DBID | M48 |
ISSN | 2056-9920 |
IngestDate | Wed Aug 27 01:31:24 EDT 2025 Thu Aug 21 14:24:46 EDT 2025 Thu Sep 04 21:56:50 EDT 2025 Mon Jun 30 04:46:34 EDT 2025 Thu Jan 02 22:55:55 EST 2025 Thu Apr 24 23:10:08 EDT 2025 Tue Jul 01 04:38:08 EDT 2025 Sat Sep 06 07:27:55 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Spectral domain optical coherence tomography Central subfield thickness Diabetic retinopathy Biomarker Receiver operator characteristic curve Ellipsoid zone Cube average thickness Area under curve |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5189-198e9875ef8a612e75a05fda57fc19a4fec33c9f307705be12a9bee7f737175e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s40942-018-0144-9 |
PMID | 30410791 |
PQID | 2135142701 |
PQPubID | 2040226 |
PageCount | 5 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_215fab2173ea40c6a6ed00d7876f2b21 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6214155 proquest_miscellaneous_2132251951 proquest_journals_2135142701 pubmed_primary_30410791 crossref_citationtrail_10_1186_s40942_018_0144_9 crossref_primary_10_1186_s40942_018_0144_9 springer_journals_10_1186_s40942_018_0144_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20181102 |
PublicationDateYYYYMMDD | 2018-11-02 |
PublicationDate_xml | – month: 11 year: 2018 text: 20181102 day: 2 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | International journal of retina and vitreous |
PublicationTitleAbbrev | Int J Retin Vitr |
PublicationTitleAlternate | Int J Retina Vitreous |
PublicationYear | 2018 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | N Mishra (144_CR24) 2015; 30 X Zhang (144_CR15) 2008; 57 HL Deissler (144_CR16) 2013; 115 S Omri (144_CR19) 2013; 8 S Ruia (144_CR7) 2016; 2 S Sharma (144_CR22) 2015; 43 N Bhagat (144_CR14) 2009; 54 American Diabetes Association (144_CR10) 2014; 37 J Cunha-Vaz (144_CR20) 2017; 1 Xu Hui-Zhuo (144_CR18) 2011; 52 N Cheung (144_CR2) 2010; 376 UEK Wolf-Schnurrbusch (144_CR12) 2009; 50 R Lee (144_CR1) 2015; 2 A Jain (144_CR6) 2013; 19 S Sinha (144_CR23) 2016; 30 SR Sharma (144_CR5) 2014; 2 P Kadam (144_CR9) 2010; 1 ETDRS Research Group (144_CR11) 1991; 98 W Li (144_CR17) 2013; 54 DF Kiernan (144_CR4) 2010; 149 144_CR13 X Zhang (144_CR3) 2014; 4 Diabetic Retinopathy Clinical Research Network (144_CR8) 2007; 114 Y Mori (144_CR25) 2016; 6 A Jain (144_CR21) 2013; 19 |
References_xml | – volume: 19 start-page: 1760 year: 2013 ident: 144_CR21 publication-title: Mol Vis – ident: 144_CR13 – volume: 8 start-page: e81600 issue: 11 year: 2013 ident: 144_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0081600 – volume: 4 start-page: 27 year: 2014 ident: 144_CR3 publication-title: Cell Biosci doi: 10.1186/2045-3701-4-27 – volume: 98 start-page: 786 year: 1991 ident: 144_CR11 publication-title: Ophthalmol doi: 10.1016/S0161-6420(13)38012-9 – volume: 54 start-page: 1 issue: 1 year: 2009 ident: 144_CR14 publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2008.10.001 – volume: 376 start-page: 124 issue: 9735 year: 2010 ident: 144_CR2 publication-title: Lancet doi: 10.1016/S0140-6736(09)62124-3 – volume: 1 start-page: 55 issue: 1 year: 2010 ident: 144_CR9 publication-title: Int J Ayurveda Res doi: 10.4103/0974-7788.59946 – volume: 30 start-page: 700 year: 2016 ident: 144_CR23 publication-title: J Diabetes Complicat doi: 10.1016/j.jdiacomp.2016.01.010 – volume: 43 start-page: 429 year: 2015 ident: 144_CR22 publication-title: Clin Exp Ophthalmol. doi: 10.1111/ceo.12506 – volume: 1 start-page: 395 year: 2017 ident: 144_CR20 publication-title: Ophthalmol Retina. doi: 10.1016/j.oret.2017.02.002 – volume: 2 start-page: 17 year: 2015 ident: 144_CR1 publication-title: Eye Vis doi: 10.1186/s40662-015-0026-2 – volume: 114 start-page: 1520 issue: 8 year: 2007 ident: 144_CR8 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.10.055 – volume: 19 start-page: 1760 year: 2013 ident: 144_CR6 publication-title: Mol Vis. – volume: 50 start-page: 3432 issue: 7 year: 2009 ident: 144_CR12 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-2970 – volume: 52 start-page: 2160 issue: 5 year: 2011 ident: 144_CR18 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.10-6518 – volume: 37 start-page: S81 year: 2014 ident: 144_CR10 publication-title: Diabetes Care doi: 10.2337/dc14-S081 – volume: 115 start-page: 162 year: 2013 ident: 144_CR16 publication-title: Exp Eye Res doi: 10.1016/j.exer.2013.07.018 – volume: 54 start-page: 219 issue: 15 year: 2013 ident: 144_CR17 publication-title: Invest Ophthalmol Vis Sci – volume: 30 start-page: 511 year: 2015 ident: 144_CR24 publication-title: J Diabetes Complicat doi: 10.1016/j.jdiacomp.2015.12.009 – volume: 6 start-page: 39161 year: 2016 ident: 144_CR25 publication-title: Sci Rep doi: 10.1038/srep39161 – volume: 149 start-page: 18 year: 2010 ident: 144_CR4 publication-title: Am J Ophthalmol doi: 10.1016/j.ajo.2009.08.037 – volume: 2 start-page: 502 issue: 5 year: 2014 ident: 144_CR5 publication-title: J Case Rep Stud. – volume: 57 start-page: 1026 issue: 4 year: 2008 ident: 144_CR15 publication-title: Diabetes doi: 10.2337/db07-0982 – volume: 2 start-page: 1 year: 2016 ident: 144_CR7 publication-title: Int J Retina Vitreous. doi: 10.1186/s40942-016-0033-z |
SSID | ssj0001651164 |
Score | 2.0978234 |
Snippet | Background
To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral... To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral domain optical... Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on spectral... Abstract Background To evaluate the association of central subfield thickness (CST) and cube average thickness (CAT) with ellipsoid zone (EZ) disruption on... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 41 |
SubjectTerms | Biomarker Biomarkers Central subfield thickness Cube average thickness Diabetes Diabetic retinopathy Edema Ellipsoid zone Glucose Medical imaging Medicine Medicine & Public Health Multivariate analysis Ophthalmology Original Original Article Oxidative stress Retina Spectral domain optical coherence tomography |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Ni9UwMMgexIv47dNVInhSyqZpPo8qLouwnlzYW0mTKRbddnndHvTsD3cm7Xu-5-fFW-lMy5CZJPM9jD0PVjTSkwsMSlkob0LhdBsLKKNMUbpWNlQofPrenJypd-f6fGfUF-WEze2B54U7wiupDQ0qzhUEJaIJBpIQCeXM4H9yCbkUXuwYU9m7YlCRMGoJY5bOHI1kyFAWAuVuKVX4vYso9-v_nZL5a67kTwHTfA8d32I3FwWSv5oJv82uQX-HXT9dQuR32bfFX8vHqcnpaZwy2j_RicZDn3icGuABBRgPkl3QyJtu6C7y0CJ6vKC8nfXIUanlkAMGQ5f416EHnrpxPeWjhnc9n723XeRUD9kPNOL4yz12dvz2w5uTYhm1UERdOl-U3oFH0wVaF1DnAauD0G0K2rax9EG1EKsq-hZPBCt0g3wNvgGwra3QHtRQ3WcHPVLwkHERbQDjATG9ilY4mxwkEMapmIQOKyY2617HpQ85jcP4XGd7xJl6ZlWNrKqJVbVfsRfbTy7nJhx_Q35NzNwiUv_s_AKlql6kqv6XVK3Y4UYU6mVTj_gRlT1IKxD8bAvG7UgxltDDMGUcScXAGnEezJKzpaQSCo1tjxC7J1N7pO5D-u5jbvltZEma34q93EjfD7L-uBKP_sdKPGY3JG0a8qTLQ3ZwtZ7gCephV83TvOW-AzWCMGo priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (Proquest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtQw0IIiIS6IN4GCjMQJFNVxHDs-IUBUFVI5UWlvkWNPIIImZdMc2jMfzozXu8vy6C2KJ9LE8_C8PMPYS2dEKy2FwKCQubLa5XXV-RwKL4OXdSdbuih8_EkfnaiPi2qRAm5TKqtc68SoqMPoKUZ-IGmUnJJGFG_OfuQ0NYqyq2mExnV2I7YuQ342C7ONsWg0J7RKycyi1gcTuTNUi0AVXErlduc4il37_2Vq_l0x-UfaNJ5Gh3fY7WRG8rcrut9l12C4x24ep0T5ffYzRW35NLexSI1TXfs30mvcDYH7uQXukI1Rnfy-NPG2H_vTOLqIHk-pemc5cTRtOcS0wdgHfjkOwEM_LeeocHg_8FUMt_ecbkUOIw06vnjATg4_fH5_lKeBC7mvitrmha3BogMDXe3Q8gFTOVF1wVWm84V1qgNflt52qBeMqFqkrrMtgOlMiV5hBeVDtjcgBo8ZF9440BYQ0ipvRG1CDQGErpUPonIZE-t9b3zqRk5DMb430SupdbMiVYOkaohUjc3Yq80nZ6tWHFcBvyNibgCpi3Z8MS6_NEkoGzR3OteiU1aCU8JrpyEIEVCHaeRRWWRsf80KTRLtqdkyYsZebJZRKCnT4gYY5wgj6UpwhTCPVpyzwaQUCl1uiytmh6d2UN1dGfqvsfG3lgXZfxl7vea-LVr_3YknV__EU3ZLkjhQpFzus73z5QzP0M46b59HYfoFMdAn2g priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1Ni9UwMOgK4kX89ukqETwpxTTN51EXl0VYTy7sraTJFItuK6_bg5794c6kfW_36Sp4K50JhMxH5juMvQxWNNJTCAxKWShvQuF0Gwsoo0xRulY21Ch8_NEcnagPp_p0GRZNvTCX8_elM29G8j-oeIBKrpQq_HV2Q5eVyXlZc3ARTjFoORi15C2vXLlz8-QB_VdZlX8WR_6WIc0Xz-EddnuxGPnbmcR32TXo77Gbx0tO_D77uQRo-Tg1uR6NUwn7F1JhPPSJx6kBHpBjUXNcBo286YbuLL9SRJ9nVKizHjlasRxyhmDoEv8x9MBTN66nrFt41_M5XNtFTg2Q_UBvGn9_wE4O3386OCqWtxWKqEvni9I78OirQOsCGjlgdRC6TUHbNpY-qBZiVUXfogqwQjdIyOAbANvaCh1ADdVDttfjDh4zLqINYDwgplfRCmeTgwTCOBWT0GHFxObc67gMHqf3L77W2QFxpp5JVSOpaiJV7Vfs1XbJt3nqxr-Q3xExt4g0MDv_QD6qF_mr0bJpQ4P-VwVBiWiCgSREQnVlkB1luWL7G1aoFykecRH1OUgrEPxiC0b5o6RK6GGYMo6k7l-NOI9mztnupBIKvWuPELvDUztb3YX03ec849vIkky9FXu94b6Lbf31JJ78F_ZTdkuSdFCMXO6zvfP1BM_QwjpvnmfZ-gXm-SB0 priority: 102 providerName: Springer Nature |
Title | Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy |
URI | https://link.springer.com/article/10.1186/s40942-018-0144-9 https://www.ncbi.nlm.nih.gov/pubmed/30410791 https://www.proquest.com/docview/2135142701 https://www.proquest.com/docview/2132251951 https://pubmed.ncbi.nlm.nih.gov/PMC6214155 https://doaj.org/article/215fab2173ea40c6a6ed00d7876f2b21 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0NqHNO0F8U1hVEbiCRRw3MSOHxDqqk1TpU4IqNS3yHEuELEl0KwS45kfzp2TFAqFB54SxWfF8n34vnzH2FOrRSYNucAglEFklA2SuHABhE7mTiaFzOii8Oxcnc2j6SJe7LC-vVW3gc1W0476Sc2XFy--frl-jQz_yjN8ol42ZKNQggGlZUVRYHbZPh5MimyxWafte5eLQu1CRV1sc-vMQ3aA9j2aRCbcOKh8Pf9tSuifuZS_BVT9OXV6k93oFEw-biniFtuB6jY7mHUh9Dvse-fP5c0q8-lrnDLeP5HE47bKuVtlwC0SOAqaX4canpV1eembGtHrJeX1LBuOSi8HH1Coy5x_qyvgedksV14U8bLirXe3dJzuS1Y1tUC-vsvmpyfvJ2dB14ohcHGYmCA0CRg0baBILOpEoGMr4iK3sS5caGxUgBuNnClQYmgRZ4h3azIAXegR2osxjO6xvQpX8IBx4bQFZQAhTeS0SHSeQA5CJZHLRWwHTPT7nrquTjm1y7hIvb2SqLTFWopYSwlrqRmwZ-spn9siHf8CPiZkrgGpvrb_UC8_pB27pqgIFTZDc20ENhJOWQW5EDlKN4XUK8MBO-pJIe1pFifRtQipBQ4_WQ8ju1IMxlZQrzyMpMvCMcLcbylnvZKe8gZMb9DUxlI3R6ryoy8JrmRImuGAPe-p7-ey_roTD__7P4_YoSSmIfe6PGJ7V8sVPEbl7Cobsl290EO2Px5P303xeXxy_uYtfp2oydA7PIaeKX8AjTk-HA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVAIuiDeBAosEF5DV9Xof3gNCFFqltIkQaqXe3PV6Ta1Su8SNUDnze_iNzPiREB699RZlJ9HaM_PtPHcIeW41S7nBEJgPeSCMskEscxf40PHM8TjnKTYKjydqtC8-HMiDFfKz74XBssoeExugziqHMfJ1jqPkBNcsfHP6NcCpUZhd7UdotGKx48-_gctWv95-D_x9wfnW5t67UdBNFQicDGMTgJftwdGWPo8tHO9eS8tknlmpcxcaK3LvosiZHIRfM5nCI1iTeq9zHYHrI30E_3uFrArsaB2Q1Y3NycdPi6iOAgNGiS59GsZqvUYHCqsfsGZMiMAsHYDNnIB_Gbd_12j-kahtzr-tm-RGZ7jSt62k3SIrvrxNro671Pwd8qOLE9N6ljZlcRQr6Y8RSaktM-pmqacWFAcA7PelmqZFVZw0w5Lw4wnWC01rCsY09U2ioioy-r0qPc2KejprII4WJW2jxoWj2IdZVjha-fwu2b8UZtwjgxJ28IBQ5rT1ynigNMJpFuss9plnKhYuY9IOCevfe-K6-89xDMeXpPGDYpW0rEqAVQmyKjFD8nL-k9P28o-LiDeQmXNCvLe7-aKafk46GEjAwMptCm5g5K1gTlnlM8YyQE0FWsHDIVnrRSHpwKROFqI_JM_mywADmNuxpa9mDQ3HJmQJNPdbyZnvJGICnHwDK3pJppa2urxSFkfNVeOKh2hxDsmrXvoW2_rvm3h48UM8JddGe-PdZHd7svOIXOeoGhin52tkcDad-cdg5Z2lTzrVouTwsrX5FwI4Zhk |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LbtQw0IIiVVwQb7YUMBInUFTHcez4CIVVebTiQKXeIseeQARNqs3mUM58ODNOdstCQeK22hlLVubheQ9jz5wRlbQUAoNUJspqlxR57RNIvQxeFrWsqFH48EgfHKt3J_nJtOe0X1W7r1KSY08DTWlql3tnoR5FvNB7PXklVFJAhVhKJfYqu6bo5aNsrd6_CLJotCe0mrKZl57ceI_i2P7LbM0_SyZ_y5vG52h-k92Y7Ej-ciT8LXYF2tts-3DKlN9hP6awLe-HKlapcSps_0qKjbs2cD9UwB3yMeqTX0E9r5quOY27i-jnKZXvLHqOti2HmDfomsC_dy3w0PSLIWoc3rR8DOI2nlNbZNvRpuPzu-x4_ubT_kEybVxIfJ4WNkltARY9GKgLh6YPmNyJvA4uN7VPrVM1-CzztkbFYEReIXmdrQBMbTJ0C3PI7rGtFm_wgHHhjQNtATGt8kYUJhQQQOhC-SByN2Ni9d1LP40jp60Y38rolhS6HElVIqlKIlVpZ-z5-sjZOIvjX8iviJhrRBqjHf_oFp_LSSpLtHdqV6FXloFTwmunIQgRUIlpZFKZztjuihXKSbZ7PETdD9IIBD9dg1EqKdXiWuiGiCOpJzhHnPsj56xvkgmFPrdFiNngqY2rbkLa5kuc_K1lSgbgjL1Ycd_Ftf76JXb-C_sJ2_74el5-eHv0_iG7LklQKIgud9nWcjHAIzTBltXjKGY_ASifK6g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Central+subfield+thickness+and+cube+average+thickness+as+bioimaging+biomarkers+for+ellipsoid+zone+disruption+in+diabetic+retinopathy&rft.jtitle=International+journal+of+retina+and+vitreous&rft.au=Ahuja%2C+Sukriti&rft.au=Saxena%2C+Sandeep&rft.au=Meyer%2C+Carsten+H.&rft.au=Gilhotra%2C+Jagjit+S.&rft.date=2018-11-02&rft.pub=BioMed+Central&rft.eissn=2056-9920&rft.volume=4&rft_id=info:doi/10.1186%2Fs40942-018-0144-9&rft_id=info%3Apmid%2F30410791&rft.externalDocID=PMC6214155 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2056-9920&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2056-9920&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2056-9920&client=summon |